Gemfibrozil
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Gemfibrozil and local guidelines before prescribing.
Fibrate
Mechanism
Fibrate with PPAR-alpha activity.
Uses
Severe hypertriglyceridaemia, pancreatitis prevention.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dyspepsia, myopathy, gallstones.
Interactions
Statins markedly increase rhabdomyolysis risk; repaglinide.
Contraindications and cautions
Liver disease, gallbladder disease
Monitoring
Lipids, LFT
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Avoid in severe renal impairment
Overdose and reversal
Supportive
Special advice
Avoid with statins.
More from the textbook: uses, cautions and other points
- Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Interacting drugs - clarithromycin, erythromycin, itraconazole, ciclosporin, gemfibrozil , amiodarone, diltiazem, verapamil, HIV protease inhibitors, grapefruit juice.
Neurology: Neuromuscular disease - Fibrates (especially gemfibrozil).
Endocrinology: Lipids and obesity
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Neurology: Neuromuscular disease (1 mention)